patrick.net

http://cepr.net/blogs/beat-the-press/protectionist-washington-post-never-mentions-role-of-patent-monopolies-in-high-prices-for-cancer-drugs

Dean Baker:

The Washington Post is well known as a hotbed of protectionist sentiment, at least when it comes to policies that redistribute income upward.
..
This patent monopoly leads to all the waste and economic distortions that economists would predict from massive tariffs. Undoubtedly many cancer patients don't get Gleevec because they can't afford its patent protected price and are not as lucky as Mr. Steiner in having a social worker who can work out an arrangement with Novartis.